Skip to content

Vote · Roll call

Amendment 2, after paragraph 5

2022 discharge: European Medicines Agency

Vote
Amendment 2, after paragraph 5
Result
96 for · 485 against · 17 abstained Rejected · roll call
Date
11 April 2024, 13:10
More facts (6)
Position
vote 3 of 6 on the decision
Requested by
roll call: ECR
Official label
A9-0133/2024 – Petri Sarvamaa – After § 5 – Am 2
Dossier
2023-2156
Vote id
168056
More

Result

The vote as recorded by name.

Result: 96 for, 485 against, 17 abstained (roll call).

Rejected · 16 % of the votes cast were for.

Groups

Members counted in their current group: the view with groups at the date of the vote is not available right now.

Members’ votes by their current group. Majority: the most common position. Clear line: a position with at least two thirds of the group’s votes, otherwise Divided.
GroupForAgainstAbst.Majority lineClear lineBar
RenewFor 2Against 37Abst. 0Majority line AgainstClear line Against
ECRFor 13Against 5Abst. 5Majority line ForClear line Divided
PatriotsFor 15Against 5Abst. 5Majority line ForClear line Divided
S&DFor 3Against 57Abst. 0Majority line AgainstClear line Against
ESNFor 4Against 0Abst. 0Majority line ForClear line For
GreensFor 3Against 22Abst. 0Majority line AgainstClear line Against
No groupFor 1Against 4Abst. 0Majority line —Clear line No line
EPPFor 1Against 78Abst. 0Majority line AgainstClear line Against
The LeftFor 0Against 12Abst. 0Majority line AgainstClear line Against

Countries × groups

How each country’s members of each group voted.

The breakdown by country is not available right now.

Members

Each member’s recorded position — groups as of today: the view with groups at the date of the vote is not available right now.

Show all 598 members

No vote recorded

Members in office that day without a recorded position. No vote recorded is not the same as absent: leave, illness or chairing the sitting look the same.

The list of members without a recorded position is not available right now.

Similar votes

Roll calls that split the chamber the most similarly: r is the correlation of members’ positions, over the members who voted in both. Other votes on the same decision are left out.

Similar votes are not available right now.

Compare with another vote

Groups’ lines side by side, and the members who switched between the two votes.

Connections

This vote’s decision, the other votes on it, and related votes.

No connections found for this vote.

Sources & citation

Where the facts on this page come from, and how to cite it.

Retrieved
26 September 2026

Cite as

European Parliament (2024). “Amendment 2, after paragraph 5 — 2022 discharge: European Medicines Agency”. Vote, 11 April 2024. votingId 168056, reference 2023-2156. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/votes/2024-04-11/168056 (retrieved 26 September 2026). Official sources: Roll-call votes, sitting of 11 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-11-RCV_EN.html; Results of votes, sitting of 11 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-11-VOT_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2024-04-11, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-04-11/vote-results?format=application%2Fld%2Bjson (CC BY 4.0).
BibTeX
@misc{epw-vote-2024-04-11-168056,
  author = {{European Parliament}},
  title = {{Amendment 2, after paragraph 5 — 2022 discharge: European Medicines Agency}},
  year = {2024},
  date = {2024-04-11},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/votes/2024-04-11/168056}},
  url = {https://news.eu-parl.st-solutions.dev/votes/2024-04-11/168056},
  urldate = {2026-09-26},
  publisher = {EU Parl Watch Research},
  note = {Vote. votingId 168056, reference 2023-2156. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-11-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-11-VOT\_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2024-04-11 (CC BY 4.0)}
}